Brian Carter Caperton

Recommended Articles

• Birth Control Patch: Pros and Cons

  What is a birth control patch?The birth control patch is a safe, simple, and affordable method of birth control. It is a transdermal patch used as a method of contraception, which can be worn on the skin of the upper arm, belly, buttocks, or back. The patch is usually changed every week for three...

• Scoliosis Pain: Treatment, Management, and Exercises

  Scoliosis is a serious condition that often occurs more in females than in males. The condition itself can be hard to diagnose at the start, which is why the healthcare professional will subject the patient to several tests, including asking them to touch their toes as well as to find out if their...

• Researchers Look to Identify Individual Symptoms of Ovarian Cancer

  Ovarian cancer is the most common and harmful type of gynecologic cancer. It can affect women of any age; however, it is generally diagnosed after menopause. The greatest risk factors for ovarian cancer are having a family history of ovarian and breast cancer (inherited genes), as well as age (most...

• Chronic Bronchitis

  Bronchitis is an inflammation of the inner lining of the bronchial tubes. It can affect anyone, regardless of their age and gender. Bronchitis may be either acute or chronic.What Is Chronic Bronchitis?Chronic bronchitis is a more severe medical condition characterized by a chronic inflammation of...

• How Does Linzess Work for IBS (Irritable Bowel Syndrome)?

  What is Linzess?Linzess is a medication used to relieve symptoms of irritable bowel syndrome with constipation (IBS‑C) and for the treatment of chronic idiopathic constipation (CIC) or chronic constipation of unknown cause. This medication works in the intestines to help reduce pain and...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...